In particular, lower levels of galectin-9 have been observed in most types of cancer cells, including oral squamous cell carcinoma[15], melanoma[16], breast cancer [17] and gastric cancer[18], than in their normal counterparts. This evidence concerns the gene LGALS9 and melanoma.